Investigation of causes of oseltamivir chemoprophylaxis failures during influenza A (H1N1-2009) outbreaks
Date
2010
Authors
Lee, Vernon
Yap, Jonathan
Maurer-Stroh, Sebastian
Lee, Raphael T.C.
Eisenhaber, Frank
Tay, Joshua K
Ting, Pei Jun
Loh, Jin Phang
Wong, Christopher W.
Tan, Boon Huan
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Background: Antiviral post-exposure prophylaxis with oseltamivir has been used as a strategy in mitigating the Influenza A (H1N1-2009) pandemic. There have been few reports of well-documented prophylaxis failures and the reasons for failure. Objectives: We report herein a series of 10 cases of prophylaxis failures and explore the reasons behind their prophylaxis failure. Study design: In the early pandemic phase, the military employed oseltamivir post-exposure ring-prophylaxis of affected units. From June 22 to July 30, 2009, cases of laboratory-confirmed prophylaxis failures were identified. Nasopharyngeal swabs were collected and tested by PCR. Samples with sufficient RNA material were sent for whole genome sequencing, and screened for mutations that confer oseltamivir resistance, especially the H275Y mutation. Results: Ten cases of laboratory-confirmed prophylaxis failure were identified, with a mean age of 22.3 years. One case was asymptomatic; the remaining 9 had fever or cough but without severe complications. The mean duration of exposure before starting oseltamivir was 1.9 days (SD 0.9), while the mean duration of oseltamivir consumption before symptom onset was 1.9 days (SD 1.4). None of the samples had the H275Y mutation or other known mutations that confer resistance. From the whole genome sequencing, several mutations at the HA (T220S, E275V, T333A, D239G); PB2 (K660R, L607V, V292I); NS1 (F103S), and NP (W104G) gene segments were detected, but none of them were likely to result in anti-viral resistance. Conclusions: Primary prophylaxis failures exhibited mild symptoms without complications; all did not have the H275Y mutation and were unlikely to result from other mutations.
Description
Keywords
Keywords: oseltamivir; virus RNA; 2009 H1N1 influenza; adult; antibiotic resistance; article; chemoprophylaxis; clinical article; clinical feature; disease duration; disease severity; female; gene mutation; gene sequence; human; human tissue; male; pandemic influen Influenza A (H1N1-2009); Oseltamivir prophylaxis; Resistance
Citation
Collections
Source
Journal of Clinical Virology
Type
Journal article
Book Title
Entity type
Access Statement
License Rights
Restricted until
2037-12-31
Downloads
File
Description